Global Alzheimer Platform Foundation Selects Cogstate
Filed with ASX · · 2 pages · English
Earlier from Cogstate
- Interim Business Update
- Cogstate cleared by FDA to start marketing Cognigram in U.S.
- FY17 Earnings Update
- Cogstate selected as preferred provider for Lilly
- Appendix 4D and Half-Year Financial Report
Later from Cogstate
- Appendix 4D & Half Year Financial Report
- S&P DJ Indices Announces March Quarterly Rebalance
- Cogstate Establishes Rare Disease and Pediatric Expertise
- Business Update & Appendix 4C
- Cogstate announces European approval for Cognigram
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate